View in EDS

Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.

Saved in:

Bibliographic Details
Title:	Clinical implications and biomarkers in the PACT-21 CASSANDRA trial.
Authors:	Neoptolemos JP; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany. Electronic address: john.neoptolemos@med.uni-heidelberg.de., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Öhlund D; Department of Diagnostics and Intervention Oncology, and Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden., Hammel P; Digestive and Medical Oncology, Hôpital Paul Brousse, Villejuif, France., Palmer DH; Cancer Research UK Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, UK.
Source:	Lancet (London, England) [Lancet] 2026 May 02; Vol. 407 (10540), pp. 1684-1685.
Publication Type:	Letter
Journal Info:	Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process
Database:	MEDLINE Ultimate

Description
ISSN:	1474-547X
DOI:	10.1016/S0140-6736(26)00641-0